0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global External Neuromodulation Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-6N6383
Home | Market Reports | Health| Nursing
Global External Neuromodulation Market Insights and Forecast to 2028
BUY CHAPTERS

Global External Neuromodulation Market Research Report 2023

Code: QYRE-Auto-6N6383
Report
March 2023
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global External Neuromodulation Market

The global External Neuromodulation market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for External Neuromodulation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for External Neuromodulation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for External Neuromodulation in Spinal Cord Stimulation is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of External Neuromodulation include Medtronic, Inc. (US), Boston Scientific Corporation (US), St. Jude Medical, Inc. (US), Synapse Biomedical, Inc. (US), Nevro Corporation (US), Neurosigma, Inc. (US), Neuropace, Inc. (US), Neuronetics, Inc. (US) and Cyberonics, Inc. (US), etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for External Neuromodulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding External Neuromodulation.
The External Neuromodulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global External Neuromodulation market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the External Neuromodulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Medtronic, Inc. (US)
  • Boston Scientific Corporation (US)
  • St. Jude Medical, Inc. (US)
  • Synapse Biomedical, Inc. (US)
  • Nevro Corporation (US)
  • Neurosigma, Inc. (US)
  • Neuropace, Inc. (US)
  • Neuronetics, Inc. (US)
  • Cyberonics, Inc. (US)
  • BioControl Medical (Israel)

Segment by Type

  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Respiratory Electrical Stimulation

Segment by Application

  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Others

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of External Neuromodulation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global External Neuromodulation Market Report

Report MetricDetails
Report NameGlobal External Neuromodulation Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global External Neuromodulation Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Transcutaneous Electrical Nerve Stimulation
1.2.3 Transcranial Magnetic Stimulation
1.2.4 Respiratory Electrical Stimulation
1.3 Market by Application
1.3.1 Global External Neuromodulation Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global External Neuromodulation Market Perspective (2018-2029)
2.2 External Neuromodulation Growth Trends by Region
2.2.1 Global External Neuromodulation Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 External Neuromodulation Historic Market Size by Region (2018-2023)
2.2.3 External Neuromodulation Forecasted Market Size by Region (2024-2029)
2.3 External Neuromodulation Market Dynamics
2.3.1 External Neuromodulation Industry Trends
2.3.2 External Neuromodulation Market Drivers
2.3.3 External Neuromodulation Market Challenges
2.3.4 External Neuromodulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top External Neuromodulation Players by Revenue
3.1.1 Global Top External Neuromodulation Players by Revenue (2018-2023)
3.1.2 Global External Neuromodulation Revenue Market Share by Players (2018-2023)
3.2 Global External Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by External Neuromodulation Revenue
3.4 Global External Neuromodulation Market Concentration Ratio
3.4.1 Global External Neuromodulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by External Neuromodulation Revenue in 2022
3.5 External Neuromodulation Key Players Head office and Area Served
3.6 Key Players External Neuromodulation Product Solution and Service
3.7 Date of Enter into External Neuromodulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 External Neuromodulation Breakdown Data by Type
4.1 Global External Neuromodulation Historic Market Size by Type (2018-2023)
4.2 Global External Neuromodulation Forecasted Market Size by Type (2024-2029)
5 External Neuromodulation Breakdown Data by Application
5.1 Global External Neuromodulation Historic Market Size by Application (2018-2023)
5.2 Global External Neuromodulation Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America External Neuromodulation Market Size (2018-2029)
6.2 North America External Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America External Neuromodulation Market Size by Country (2018-2023)
6.4 North America External Neuromodulation Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe External Neuromodulation Market Size (2018-2029)
7.2 Europe External Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe External Neuromodulation Market Size by Country (2018-2023)
7.4 Europe External Neuromodulation Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific External Neuromodulation Market Size (2018-2029)
8.2 Asia-Pacific External Neuromodulation Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific External Neuromodulation Market Size by Region (2018-2023)
8.4 Asia-Pacific External Neuromodulation Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America External Neuromodulation Market Size (2018-2029)
9.2 Latin America External Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America External Neuromodulation Market Size by Country (2018-2023)
9.4 Latin America External Neuromodulation Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa External Neuromodulation Market Size (2018-2029)
10.2 Middle East & Africa External Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa External Neuromodulation Market Size by Country (2018-2023)
10.4 Middle East & Africa External Neuromodulation Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic, Inc. (US)
11.1.1 Medtronic, Inc. (US) Company Detail
11.1.2 Medtronic, Inc. (US) Business Overview
11.1.3 Medtronic, Inc. (US) External Neuromodulation Introduction
11.1.4 Medtronic, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)
11.1.5 Medtronic, Inc. (US) Recent Development
11.2 Boston Scientific Corporation (US)
11.2.1 Boston Scientific Corporation (US) Company Detail
11.2.2 Boston Scientific Corporation (US) Business Overview
11.2.3 Boston Scientific Corporation (US) External Neuromodulation Introduction
11.2.4 Boston Scientific Corporation (US) Revenue in External Neuromodulation Business (2018-2023)
11.2.5 Boston Scientific Corporation (US) Recent Development
11.3 St. Jude Medical, Inc. (US)
11.3.1 St. Jude Medical, Inc. (US) Company Detail
11.3.2 St. Jude Medical, Inc. (US) Business Overview
11.3.3 St. Jude Medical, Inc. (US) External Neuromodulation Introduction
11.3.4 St. Jude Medical, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)
11.3.5 St. Jude Medical, Inc. (US) Recent Development
11.4 Synapse Biomedical, Inc. (US)
11.4.1 Synapse Biomedical, Inc. (US) Company Detail
11.4.2 Synapse Biomedical, Inc. (US) Business Overview
11.4.3 Synapse Biomedical, Inc. (US) External Neuromodulation Introduction
11.4.4 Synapse Biomedical, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)
11.4.5 Synapse Biomedical, Inc. (US) Recent Development
11.5 Nevro Corporation (US)
11.5.1 Nevro Corporation (US) Company Detail
11.5.2 Nevro Corporation (US) Business Overview
11.5.3 Nevro Corporation (US) External Neuromodulation Introduction
11.5.4 Nevro Corporation (US) Revenue in External Neuromodulation Business (2018-2023)
11.5.5 Nevro Corporation (US) Recent Development
11.6 Neurosigma, Inc. (US)
11.6.1 Neurosigma, Inc. (US) Company Detail
11.6.2 Neurosigma, Inc. (US) Business Overview
11.6.3 Neurosigma, Inc. (US) External Neuromodulation Introduction
11.6.4 Neurosigma, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)
11.6.5 Neurosigma, Inc. (US) Recent Development
11.7 Neuropace, Inc. (US)
11.7.1 Neuropace, Inc. (US) Company Detail
11.7.2 Neuropace, Inc. (US) Business Overview
11.7.3 Neuropace, Inc. (US) External Neuromodulation Introduction
11.7.4 Neuropace, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)
11.7.5 Neuropace, Inc. (US) Recent Development
11.8 Neuronetics, Inc. (US)
11.8.1 Neuronetics, Inc. (US) Company Detail
11.8.2 Neuronetics, Inc. (US) Business Overview
11.8.3 Neuronetics, Inc. (US) External Neuromodulation Introduction
11.8.4 Neuronetics, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)
11.8.5 Neuronetics, Inc. (US) Recent Development
11.9 Cyberonics, Inc. (US)
11.9.1 Cyberonics, Inc. (US) Company Detail
11.9.2 Cyberonics, Inc. (US) Business Overview
11.9.3 Cyberonics, Inc. (US) External Neuromodulation Introduction
11.9.4 Cyberonics, Inc. (US) Revenue in External Neuromodulation Business (2018-2023)
11.9.5 Cyberonics, Inc. (US) Recent Development
11.10 BioControl Medical (Israel)
11.10.1 BioControl Medical (Israel) Company Detail
11.10.2 BioControl Medical (Israel) Business Overview
11.10.3 BioControl Medical (Israel) External Neuromodulation Introduction
11.10.4 BioControl Medical (Israel) Revenue in External Neuromodulation Business (2018-2023)
11.10.5 BioControl Medical (Israel) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global External Neuromodulation Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Transcutaneous Electrical Nerve Stimulation
    Table 3. Key Players of Transcranial Magnetic Stimulation
    Table 4. Key Players of Respiratory Electrical Stimulation
    Table 5. Global External Neuromodulation Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global External Neuromodulation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global External Neuromodulation Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global External Neuromodulation Market Share by Region (2018-2023)
    Table 9. Global External Neuromodulation Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global External Neuromodulation Market Share by Region (2024-2029)
    Table 11. External Neuromodulation Market Trends
    Table 12. External Neuromodulation Market Drivers
    Table 13. External Neuromodulation Market Challenges
    Table 14. External Neuromodulation Market Restraints
    Table 15. Global External Neuromodulation Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global External Neuromodulation Market Share by Players (2018-2023)
    Table 17. Global Top External Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in External Neuromodulation as of 2022)
    Table 18. Ranking of Global Top External Neuromodulation Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by External Neuromodulation Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players External Neuromodulation Product Solution and Service
    Table 22. Date of Enter into External Neuromodulation Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global External Neuromodulation Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global External Neuromodulation Revenue Market Share by Type (2018-2023)
    Table 26. Global External Neuromodulation Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global External Neuromodulation Revenue Market Share by Type (2024-2029)
    Table 28. Global External Neuromodulation Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global External Neuromodulation Revenue Market Share by Application (2018-2023)
    Table 30. Global External Neuromodulation Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global External Neuromodulation Revenue Market Share by Application (2024-2029)
    Table 32. North America External Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America External Neuromodulation Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America External Neuromodulation Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe External Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe External Neuromodulation Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe External Neuromodulation Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific External Neuromodulation Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific External Neuromodulation Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific External Neuromodulation Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America External Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America External Neuromodulation Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America External Neuromodulation Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa External Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa External Neuromodulation Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa External Neuromodulation Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Medtronic, Inc. (US) Company Detail
    Table 48. Medtronic, Inc. (US) Business Overview
    Table 49. Medtronic, Inc. (US) External Neuromodulation Product
    Table 50. Medtronic, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)
    Table 51. Medtronic, Inc. (US) Recent Development
    Table 52. Boston Scientific Corporation (US) Company Detail
    Table 53. Boston Scientific Corporation (US) Business Overview
    Table 54. Boston Scientific Corporation (US) External Neuromodulation Product
    Table 55. Boston Scientific Corporation (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)
    Table 56. Boston Scientific Corporation (US) Recent Development
    Table 57. St. Jude Medical, Inc. (US) Company Detail
    Table 58. St. Jude Medical, Inc. (US) Business Overview
    Table 59. St. Jude Medical, Inc. (US) External Neuromodulation Product
    Table 60. St. Jude Medical, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)
    Table 61. St. Jude Medical, Inc. (US) Recent Development
    Table 62. Synapse Biomedical, Inc. (US) Company Detail
    Table 63. Synapse Biomedical, Inc. (US) Business Overview
    Table 64. Synapse Biomedical, Inc. (US) External Neuromodulation Product
    Table 65. Synapse Biomedical, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)
    Table 66. Synapse Biomedical, Inc. (US) Recent Development
    Table 67. Nevro Corporation (US) Company Detail
    Table 68. Nevro Corporation (US) Business Overview
    Table 69. Nevro Corporation (US) External Neuromodulation Product
    Table 70. Nevro Corporation (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)
    Table 71. Nevro Corporation (US) Recent Development
    Table 72. Neurosigma, Inc. (US) Company Detail
    Table 73. Neurosigma, Inc. (US) Business Overview
    Table 74. Neurosigma, Inc. (US) External Neuromodulation Product
    Table 75. Neurosigma, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)
    Table 76. Neurosigma, Inc. (US) Recent Development
    Table 77. Neuropace, Inc. (US) Company Detail
    Table 78. Neuropace, Inc. (US) Business Overview
    Table 79. Neuropace, Inc. (US) External Neuromodulation Product
    Table 80. Neuropace, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)
    Table 81. Neuropace, Inc. (US) Recent Development
    Table 82. Neuronetics, Inc. (US) Company Detail
    Table 83. Neuronetics, Inc. (US) Business Overview
    Table 84. Neuronetics, Inc. (US) External Neuromodulation Product
    Table 85. Neuronetics, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)
    Table 86. Neuronetics, Inc. (US) Recent Development
    Table 87. Cyberonics, Inc. (US) Company Detail
    Table 88. Cyberonics, Inc. (US) Business Overview
    Table 89. Cyberonics, Inc. (US) External Neuromodulation Product
    Table 90. Cyberonics, Inc. (US) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)
    Table 91. Cyberonics, Inc. (US) Recent Development
    Table 92. BioControl Medical (Israel) Company Detail
    Table 93. BioControl Medical (Israel) Business Overview
    Table 94. BioControl Medical (Israel) External Neuromodulation Product
    Table 95. BioControl Medical (Israel) Revenue in External Neuromodulation Business (2018-2023) & (US$ Million)
    Table 96. BioControl Medical (Israel) Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global External Neuromodulation Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global External Neuromodulation Market Share by Type: 2022 VS 2029
    Figure 3. Transcutaneous Electrical Nerve Stimulation Features
    Figure 4. Transcranial Magnetic Stimulation Features
    Figure 5. Respiratory Electrical Stimulation Features
    Figure 6. Global External Neuromodulation Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global External Neuromodulation Market Share by Application: 2022 VS 2029
    Figure 8. Spinal Cord Stimulation Case Studies
    Figure 9. Deep Brain Stimulation Case Studies
    Figure 10. Sacral Nerve Stimulation Case Studies
    Figure 11. Others Case Studies
    Figure 12. External Neuromodulation Report Years Considered
    Figure 13. Global External Neuromodulation Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global External Neuromodulation Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global External Neuromodulation Market Share by Region: 2022 VS 2029
    Figure 16. Global External Neuromodulation Market Share by Players in 2022
    Figure 17. Global Top External Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in External Neuromodulation as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by External Neuromodulation Revenue in 2022
    Figure 19. North America External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America External Neuromodulation Market Share by Country (2018-2029)
    Figure 21. United States External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Canada External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe External Neuromodulation Market Share by Country (2018-2029)
    Figure 25. Germany External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. France External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. U.K. External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Italy External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Russia External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Nordic Countries External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific External Neuromodulation Market Share by Region (2018-2029)
    Figure 33. China External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Japan External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. South Korea External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Southeast Asia External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. India External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Australia External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America External Neuromodulation Market Share by Country (2018-2029)
    Figure 41. Mexico External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Brazil External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa External Neuromodulation Market Share by Country (2018-2029)
    Figure 45. Turkey External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Saudi Arabia External Neuromodulation Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Medtronic, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)
    Figure 48. Boston Scientific Corporation (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)
    Figure 49. St. Jude Medical, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)
    Figure 50. Synapse Biomedical, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)
    Figure 51. Nevro Corporation (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)
    Figure 52. Neurosigma, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)
    Figure 53. Neuropace, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)
    Figure 54. Neuronetics, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)
    Figure 55. Cyberonics, Inc. (US) Revenue Growth Rate in External Neuromodulation Business (2018-2023)
    Figure 56. BioControl Medical (Israel) Revenue Growth Rate in External Neuromodulation Business (2018-2023)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Hospice Software Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Geriatric Care Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Organ Preservation Technology Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8W13102
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Haemorrhoidal Energy Therapy (HET) Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17Q15432
Thu May 16 00:00:00 UTC 2024

Add to Cart